Cross Country Healthcare, Inc.

As of March 31, 2026, Cross Country Healthcare, Inc. carries a market capitalization of 256.18M, placing it among publicly traded companies globally. Its enterprise value stands at 166.61M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cross Country Healthcare, Inc.'s next confirmed earnings release is scheduled for August 5, 2026.

As of March 31, 2026, Cross Country Healthcare, Inc. has 31.24M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.30, and the price-to-book ratio stands at 0.95.

These figures are as of March 31, 2026. The EV/Sales ratio of 0.19 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 166.61M versus a market cap of 256.18M, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Cross Country Healthcare, Inc. maintains a current ratio of 3.29, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.65, indicating moderate leverage, while an interest coverage ratio of -32.10 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. posted a negative return on equity (ROE) of -26.98, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -19.20, reflecting losses generated across the asset base. The company generates approximately 691,763.79 in revenue per employee across its workforce of 1,253.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. recorded 10.63M in income tax expense. The company reported a pretax loss of -74.70M and -85.32M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on July 20, 2026, Cross Country Healthcare, Inc.'s stock has gained approximately 6.42% over the past 52 weeks. The 50-day moving average sits at 11.41, while the 200-day moving average is 9.35.

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. generated 866.78M in revenue and converted that into -85.32M in net income, yielding earnings per share of -2.65. EBITDA reached -62.20M, while operating income came in at -6.22M.

As of March 31, 2026, Cross Country Healthcare, Inc. holds 91.34M in cash and equivalents against 1.77M in total debt, resulting in a net debt position of -91.34M. Total book value stands at 270.61M, with working capital of 179.71M providing operational flexibility.

Cross Country Healthcare, Inc. produced 40.95M in operating cash flow over the twelve months ended March 31, 2026. After subtracting -6.69M in capital expenditures, free cash flow totaled 34.26M - equivalent to 1.06 per share.

Over the twelve months ended March 31, 2026, Cross Country Healthcare, Inc. posted a gross margin of 20.21, reflecting its pricing power and cost economics. The operating margin of -0.72 and net profit margin of -9.84 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 12.97, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 4.98, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cross Country Healthcare, Inc. shareholders.

As of March 31, 2026, Cross Country Healthcare, Inc. has an Altman Z-Score of 5.14, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.